Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Johnson & Johnson and every other company we cover.
Try it first on NVDA, AAPL, META, NKE or CAKE, where it is open to everyone.
$286.06+0.9%Nov 13 close
Figures through September 27, 2026, from the 10-Q filed October 21, 2026
Makes prescription medicines and medical devices for cancer, immune disorders, surgery, heart care, joint replacement and vision.